AF
ABBV icon

Arrow Financial’s AbbVie ABBV Stock Holding History

Arrow Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.28M Sell
5,899
-270
-4% -$59.9K 0.13% 89
2025
Q4 		$1.41M Buy
6,169
+445
+8% +$101K 0.14% 84
2025
Q3 		$1.33M Sell
5,724
-27
-0.5% -$5.5K 0.14% 86
2025
Q2 		$1.07M Sell
5,751
-205
-3% -$38.1K 0.11% 93
2025
Q1 		$1.25M Sell
5,956
-21
-0.4% -$4.08K 0.14% 88
2024
Q4 		$1.06M Sell
5,977
-21
-0.4% -$3.86K 0.1% 104
2024
Q3 		$1.18M Sell
5,998
-7
-0.1% -$1.31K 0.11% 101
2024
Q2 		$1.03M Sell
6,005
-125
-2% -$20.7K 0.1% 104
2024
Q1 		$1.12M Sell
6,130
-160
-3% -$27.6K 0.11% 103
2023
Q4 		$975K Sell
6,290
-110
-2% -$16K 0.1% 107
2023
Q3 		$954K Sell
6,400
-377
-6% -$55.3K 0.11% 101
2023
Q2 		$913K Sell
6,777
-455
-6% -$66.7K 0.11% 105
2023
Q1 		$1.15M Sell
7,232
-517
-7% -$79K 0.15% 99
2022
Q4 		$1.25M Sell
7,749
-91
-1% -$14K 0.17% 94
2022
Q3 		$1.05M Sell
7,840
-120
-2% -$17.2K 0.15% 99
2022
Q2 		$1.22M Sell
7,960
-25
-0.3% -$3.82K 0.17% 93
2022
Q1 		$1.29M Sell
7,985
-535
-6% -$77.7K 0.15% 96
2021
Q4 		$1.15M Buy
8,520
+139
+2% +$16.4K 0.14% 95
2021
Q3 		$904K Sell
8,381
-122
-1% -$13.9K 0.12% 107
2021
Q2 		$959K Sell
8,503
-66
-0.8% -$7.43K 0.12% 105
2021
Q1 		$928K Buy
8,569
+40
+0.5% +$4.28K 0.12% 105
2020
Q4 		$914K Sell
8,529
-27
-0.3% -$2.6K 0.18% 92
2020
Q3 		$749K Sell
8,556
-172
-2% -$16.2K 0.16% 104
2020
Q2 		$858K Buy
8,728
+547
+7% +$48.2K 0.19% 94
2020
Q1 		$623K Buy
8,181
+145
+2% +$12.4K 0.15% 104
2019
Q4 		$713K Sell
8,036
-1,435
-15% -$119K 0.14% 109
2019
Q3 		$717K Sell
9,471
-25
-0.3% -$1.71K 0.15% 107
2019
Q2 		$690K Hold
9,496
– – 0.15% 108
2019
Q1 		$765K Hold
9,496
– – 0.18% 105
2018
Q4 		$875K Buy
9,496
+5
+0.1% +$440 0.22% 94
2018
Q3 		$898K Sell
9,491
-13,025
-58% -$1.24M 0.19% 101
2018
Q2 		$2.09M Hold
22,516
– – 0.47% 55
2018
Q1 		$2.13M Buy
22,516
+12,775
+131% +$1.4M 0.49% 54
2017
Q4 		$941K Sell
9,741
-28
-0.3% -$2.64K 0.22% 97
2017
Q3 		$867K Sell
9,769
-1,000
-9% -$76.1K 0.21% 100
2017
Q2 		$781K Sell
10,769
-60
-0.6% -$4.03K 0.19% 108
2017
Q1 		$706K Sell
10,829
-110
-1% -$6.92K 0.17% 107
2016
Q4 		$685K Sell
10,939
-197
-2% -$12K 0.17% 105
2016
Q3 		$702K Sell
11,136
-375
-3% -$24.3K 0.18% 102
2016
Q2 		$713K Sell
11,511
-170
-1% -$10.4K 0.19% 107
2016
Q1 		$667K Sell
11,681
-986
-8% -$55K 0.18% 106
2015
Q4 		$751K Sell
12,667
-100
-0.8% -$5.76K 0.2% 97
2015
Q3 		$695K Buy
12,767
+725
+6% +$47.2K 0.2% 98
2015
Q2 		$809K Sell
12,042
-2,185
-15% -$143K 0.22% 101
2015
Q1 		$833K Sell
14,227
-1,545
-10% -$93.3K 0.22% 104
2014
Q4 		$1.03M Sell
15,772
-1,096
-6% -$69.1K 0.28% 97
2014
Q3 		$976K Sell
16,868
-504
-3% -$28K 0.27% 101
2014
Q2 		$980K Buy
17,372
+500
+3% +$26.2K 0.26% 109
2014
Q1 		$866K Sell
16,872
-825
-5% -$41.7K 0.25% 111
2013
Q4 		$935K Sell
17,697
-600
-3% -$29.5K 0.27% 103
2013
Q3 		$819K Sell
18,297
-4,680
-20% -$207K 0.25% 107
2013
Q2 		$950K Buy
+22,977
New +$1M 0.3% 100

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrow Financial's ABBV Position: Q1 2026 in Review

Arrow Financial reduced its AbbVie (ABBV) stake by 4.4% in Q1 2026, selling an estimated $59.9K and leaving 5,899 shares worth $1.28M. The position accounts for 0.13% of the portfolio, ranked #89.

Arrow Financial first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.13M in Q1 2018. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Arrow Financial held 5,899 shares of AbbVie worth $1.28M as of Q1 2026.
  • Arrow Financial sold 270 AbbVie shares in Q1 2026, an estimated $59.9K.
  • AbbVie made up 0.13% of Arrow Financial's portfolio in Q1 2026, its #89 holding.
  • Arrow Financial first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Arrow Financial's AbbVie position peaked at $2.13M in Q1 2018.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Arrow Financial's 13F filing for Q1 2026, filed 11 May 2026.